186 related articles for article (PubMed ID: 31493778)
41. Caspase-dependent Mcl-1 cleavage and effect of Mcl-1 phosphorylation in ABT-737-induced apoptosis in human acute lymphoblastic leukemia cell lines.
Ryu Y; Hall CP; Reynolds CP; Kang MH
Exp Biol Med (Maywood); 2014 Oct; 239(10):1390-402. PubMed ID: 24951472
[TBL] [Abstract][Full Text] [Related]
42. Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1.
Zhang S; Li G; Ma X; Wang Y; Liu G; Feng L; Zhao Y; Zhang G; Wu Y; Ye X; Qin B; Lu J
Cell Signal; 2012 Sep; 24(9):1803-9. PubMed ID: 22609455
[TBL] [Abstract][Full Text] [Related]
43. Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner.
Kiprianova I; Remy J; Milosch N; Mohrenz IV; Seifert V; Aigner A; Kögel D
Neoplasia; 2015 Jul; 17(7):564-73. PubMed ID: 26297434
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of p38 MAPK enhances ABT-737-induced cell death in melanoma cell lines: novel regulation of PUMA.
Keuling AM; Andrew SE; Tron VA
Pigment Cell Melanoma Res; 2010 Jun; 23(3):430-40. PubMed ID: 20337986
[TBL] [Abstract][Full Text] [Related]
45. Cell Death Induction by the Indirubin Derivative 7BIO and the BH3 Mimetic Drugs ABT-737 and GX15-070 in Medullary Thyroid Carcinoma Cells.
Broecker-Preuss M; Becher-Boveleth N; Mann K
Exp Clin Endocrinol Diabetes; 2016 May; 124(5):324-30. PubMed ID: 26849668
[TBL] [Abstract][Full Text] [Related]
46. Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression.
Lutz C; Mozaffari M; Tosevski V; Caj M; Cippà P; McRae BL; Graff CL; Rogler G; Fried M; Hausmann M
Clin Exp Immunol; 2015 Aug; 181(2):343-56. PubMed ID: 25845418
[TBL] [Abstract][Full Text] [Related]
47. Anticancer agent ABT-737 possesses anti-atopic dermatitis activity via blockade of caspase-1 in atopic dermatitis in vitro and in vivo models.
Jeong HJ; Ryu KJ; Kim HM
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):319-326. PubMed ID: 29957081
[TBL] [Abstract][Full Text] [Related]
48. Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer.
Sakakibara-Konishi J; Ikezawa Y; Oizumi S; Kikuchi J; Kikuchi E; Mizugaki H; Kinoshita I; Dosaka-Akita H; Nishimura M
Int J Clin Oncol; 2017 Apr; 22(2):257-268. PubMed ID: 27816990
[TBL] [Abstract][Full Text] [Related]
49. ML355 Modulates Platelet Activation and Prevents ABT-737 Induced Apoptosis in Platelets.
Shpakova V; Rukoyatkina N; Al Arawe N; Prilepskaya A; Kharazova A; Sharina I; Gambaryan S; Martin E
J Pharmacol Exp Ther; 2022 May; 381(2):164-175. PubMed ID: 35197320
[TBL] [Abstract][Full Text] [Related]
50. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
[TBL] [Abstract][Full Text] [Related]
51. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.
Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD
Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615
[TBL] [Abstract][Full Text] [Related]
52. Complementary roles of platelet α
Heinzmann ACA; Karel MFA; Coenen DM; Vajen T; Meulendijks NMM; Nagy M; Suylen DPL; Cosemans JMEM; Heemskerk JWM; Hackeng TM; Koenen RR
Atherosclerosis; 2020 Oct; 310():17-25. PubMed ID: 32877806
[TBL] [Abstract][Full Text] [Related]
53. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
54. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation.
Wolf BB; Goldstein JC; Stennicke HR; Beere H; Amarante-Mendes GP; Salvesen GS; Green DR
Blood; 1999 Sep; 94(5):1683-92. PubMed ID: 10477693
[TBL] [Abstract][Full Text] [Related]
55. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL
Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401
[TBL] [Abstract][Full Text] [Related]
56. Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis.
Zhang E; Yin S; Lu X; Ye L; Fan L; Hu H
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29543705
[TBL] [Abstract][Full Text] [Related]
57. Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia.
Bonomini M; Dottori S; Amoroso L; Arduini A; Sirolli V
J Thromb Haemost; 2004 Aug; 2(8):1275-81. PubMed ID: 15304031
[TBL] [Abstract][Full Text] [Related]
58. Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan.
Liu ZJ; Hoffmeister KM; Hu Z; Mager DE; Ait-Oudhia S; Debrincat MA; Pleines I; Josefsson EC; Kile BT; Italiano J; Ramsey H; Grozovsky R; Veng-Pedersen P; Chavda C; Sola-Visner M
Blood; 2014 May; 123(22):3381-9. PubMed ID: 24599546
[TBL] [Abstract][Full Text] [Related]
59. L-carnitine inhibits a subset of platelet activation responses in chronic uraemia.
Bonomini M; Sirolli V; Dottori S; Amoroso L; Di Liberato L; Arduini A
Nephrol Dial Transplant; 2007 Sep; 22(9):2623-9. PubMed ID: 17478491
[TBL] [Abstract][Full Text] [Related]
60. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]